An International, Multicenter, Prospective Observational Study of the Safety of Maraviroc Used with Optimized Background Therapy in Treatment-Experienced HIV-1 Infected Patients

August 10, 2018
https://clinicaltrials.gov/ct2/show/NCT00665561
Infectious Disease
Principal Investigator: Norman P Markowitz, MD

 Maraviroc, HIV-1 Patients

Accepting Participants